Document is current
Any future updates will be listed below
-
Authors
Denimal, Damien
Ponnaiah, Maharajah
Phan, Franck
Jeannin, Anne-Caroline
Redheuil, Alban
Salem, Joe-Elie
Boussouar, Samia
Paulstephenraj, Pauline
Laroche, Suzanne
Amouyal, Chloé
Hartemann, Agnès
Foufelle, Fabienne
Bourron, Olivier
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02431234 at ClinicalTrials.govDocuments that mention this clinical trial
Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy
https://doi.org/10.1186/s13098-019-0429-7
Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study
https://doi.org/10.1186/s12933-020-01122-4
Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study
https://doi.org/10.1186/s12933-025-02705-9
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts
https://doi.org/10.1186/s12933-024-02161-x
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 24 March 2025
First Online: 23 April 2025
Declarations
:
: This study involving human participants have been performed in accordance with the Declaration of Helsinki and have been approved by our local ethics committee.
: Not applicable.
: The authors declare that they have no competing interests.
